ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4~10 ng/mL: Biparametric versus multiparametric MRI

Han, C.; Liu, S.; Qin, X. B.; Ma, S.; Zhu, L. N.; Wang, X. Y.*北京大学
Diagnostic and Interventional Imaging2020-4DOI: 10.1016/j.diii.2020.01.014
40被引2阅读
引用收藏
分享

摘要

Purpose: To compare the performance of biparametric magnetic resonance imaging (bpMRI) to that of multiparametric MRI (mpMR)) in combination with prostate-specific antigen density (PSAD) in detecting clinically significant prostate cancer (csPCa) in patients with PSA serum levels of 4 similar to 10 ng/mL. Materials and methods: A total of 123 men (mean age, 66.3 +/- 8.9 [SD]; range: 42-83 years) with PSA serum levels of 4 similar to 10 ng/mL with suspected csPCa were included. All patients underwent mpMRI at 3 Tesla and transrectal ultrasound-guided prostate biopsy in their clinical workup and were followed-up for >1 year when no csPCa was found at initial biopsy. The mpMRI images were reinterpreted according to the Prostate Imaging Reporting and Data System (PI-RADS, v2.1) twice in two different sessions using either mpMRI sequences or bpMRI sequences. The patients were divided into 2 groups according to whether csPCa was detected. The PI-RADS (mpMRI or bpMRI) categories and PSAD were used in combination to detect csPCa. Receiver operating characteristic (ROC) curve and decision curve analyses were performed to compare the efficacy of the different models (mpMRI, bpMRI, PSAD, mpMRI + PSAD and bpMRI + PSAD). Results: Thirty-seven patients (30.1%, 37/123) had csPCa. ROC analysis showed that bpMRI (AUC= 0.884 [95% confidence interval (CI): 0.814-0.935]) outperformed mpMRl (AUC = 0.867 [95% CI: 0.794-0.921]) (P= 0.035) and that bpMRI and mpMRI performed better than PSAD (0.682 [95% CI: 0.592-0.763]) in detecting csPCa; bpMRI + PSAD (AUC = 0.907 [95% CI: 0.841-0.952]) performed similarly to mpMRI + PSAD (AUC = 0.896 [95% CI: 0.828-0.944] ) (P = 0.151) and bpMRI (P=0.224). The sensitivity and specificity were 81.1% (95% CI: 64.8-92.0%) and 88.4% (95% CI: 79.7-94.3%), respectively for bpMRI, and 83.8% (95% CI: 68.0-93.8%) and 80.2% (95% CI: 70.2-88.0%), respectively for mpMRI (P 0.999 for sensitivity and P=0.016 for specificity). Among the 5 decision models, the decision curve analysis showed that all models (except for PSAD) achieved a high net benefit. Conclusion: In patients with PSA serum levels of 4 similar to 10 ng/mL, bpMRI and bpMRI combined with PSAD achieve better performance than mpMRI in detecting csPCa; bpMRI has a higher specificity than mpMRI, which could decrease unnecessary biopsy, and may serve as a potential alternative to mpMRI to optimize clinical workup.

学科与关键词

关键词
Prostate neoplasmsMagnetic resonance imaging (MRI)Prostate-specific antigenGadolinium chelate
相关
加载中…
  • Diagnostic value of integrated 18F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer
    Zeng, Yuping; Leng, Xiaoming; Liao, Hengbin; Jiang, Guihua*; Chen, Ping*Prostate International, 2022, 10(2): 108-116.被引 3
  • Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study
    Zhao, Litao; Bao, Jie; Qiao, Xiaomeng; Jin, Pengfei; Ji, Yanting; Li, Zhenkai; Zhang, Ji; Su, Yueting; Ji, Libiao; Shen, Junkang; Zhang, Yueyue; Niu, Lei; Xie, Wanfang; Hu, Chunhong; Shen, Hailin*; Wang, Ximing*; Liu, Jiangang*; Tian, Jie*European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50(3): 727-741.被引 12
  • Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers
    Rouviere, Olivier; Dagonneau, Tristan; Cros, Fanny; Bratan, Flavie; Roche, Laurent; Mege-Lechevallier, Florence; Ruffion, Alain; Crouzet, Sebastien; Colombel, Marc; Rabilloud, MurielPLoS One, 2017, 12(6): e0178901.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Diagnostic and Interventional Imaging
发表日期
2020-04
卷期
第 101 卷, 第 4 期
页码
235-244
DOI
10.1016/j.diii.2020.01.014
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIE

作者

  • H

    Han, C. (第一作者)

    peking univ

  • L

    Liu, S.

    peking univ

查看全部 6 位作者收起作者
  • Q

    Qin, X. B.

    peking univ

  • M

    Ma, S.

    peking univ

  • Z

    Zhu, L. N.

    peking univ

  • W

    Wang, X. Y. (通讯)

    peking univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417